Fudan University: all 1,308 studies

Page 11 of 14. Open to participants first (637), then studies with results posted, then the rest; newest registration first within each.

• Endostar Combined With IP Second-line Treatment of Advanced Esophageal Squamous Cell CarcinomasCompletedNCT03797625Phase 2
• Laparoscopic vs Open Pancreatectomy for Body and Tail Pancreatic CancerStatus unknownNCT03792932Not applicable
• CD155 in Bladder CancerCompletedNCT03789682
• Short-term Health Benefits of Using Fresh Air Filtration System in ClassroomCompletedNCT03788330Not applicable
• Application of Radiomics in Precise Preoperative Diagnosis and Prognsis Evaluation of Colorectal Cancer.Status unknownNCT03787667
• TACE(Transcatheter Arterial Chemoembolization ) Associated With Systemic Chemotherapy Versus Systemic Chemotherapy Alone in Patients With Unresectable CRLM(Colorectal Liver Metastases)Status unknownNCT03783559Phase 3
• Pyrotinib, Dalpiciclib(SHR6390) and Endocrine Therapy in Subjects With Dual-receptor Positive(ER+/HER2+) Advanced Breast CancerActive, not recruitingNCT03772353Phase 1/2
• X-396(Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain MetastasesActive, not recruitingNCT03753685Phase 2
• The Implication of Plasma ctDNA Methylation Haplotypes in Detecting Colorectal Cancer and AdenomasCompletedNCT03737591
• Everolimus Related Pneumonitis in MBCCompletedNCT03730428
• CRT Versus Surgery for Retroperitoneal or Paraaortic Lymph Node Recurrence of CRCStatus unknownNCT03725254Phase 2
• Evaluation of the Efficacy for Sentinel Lymph Node Policy in High-risk Endometrial CarcinomaCompletedNCT03716414
• 500mg Fulvestrant in HR+ MBCCompletedNCT03708432
• Radiation-protection Effect of Amifostine in Locally Advanced Rectal CancerStatus unknownNCT03702985Phase 2
• Effects of Fish Oil in Alleviating Health Hazards Associated With Ozone ExposureCompletedNCT03697499Not applicable
• Acute Health Effects of Ozone ExposureCompletedNCT03697174Not applicable
• 500mg Fulvestrant Versus Everolimus Plus Exemestane in MBC Patients Refractory to Previous AICompletedNCT03695341
• Is Bone Scintigraphy Necessary in cT1N0M0 GGO Non-Small Cell Lung Cancer? (ECTOP-1006)CompletedNCT03689439
• A Model for Predicting the Efficacy of Conversion Therapy for Patients With Colorectal Cancer Liver Metastases by the Detection of 5-hydroxymethylcytosine (5-hmC) in Plasma Cell-free DNAStatus unknownNCT03679039
• Evaluation of the Efficacy for Sentinel Lymph Node Policy in Intermediate-risk Endometrial CarcinomasWithdrawnNCT03677024Not applicable
• A Multi-center Trial to Establish a Model for the Early Diagnosis of Colorectal Cancer by the Detection of 5-hydroxymethylcytosine (5-hmC) in Plasma Cell-free DNAStatus unknownNCT03676075
• S-1 Combined With IMRT Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal CarcinomaCompletedNCT03668366Phase 2
• Effects of Epidural Block on the Prognosis in Patients With Pancreatic Cancer Undergoing Distal PancreatectomyStatus unknownNCT03659292Not applicable
• Predictive Value of Intraoperative Indocyanine Green Clearance Test After Partially Blood Flow Blocking in Postoperative Liver ReserveStatus unknownNCT03654183
• Evaluation the Treatment Outcome for RFA in Patients With BCLC Stage B HCC in Comparison With TACEStatus unknownNCT03642561Phase 2/3
• Chidamide Combined With Cisplatin in Head and Neck Adenoid Cystic Carcinoma (HNACC)CompletedNCT03639168Phase 2
• TACE Combined With RFA/MV Treatment in Hepatocellular Carcinoma Beyond Milan CriterialCompletedNCT03636620Phase 3
• Comparison of Epidural Labor Analgesia With Dexmedetomidine or SufentanilStatus unknownNCT03622047Not applicable
• Application of Left Colic Artery Preservation, Anastomotic Reinforcing Sutures and Transanal Tube in Robotic Low Anterior ResectionStatus unknownNCT03609710Not applicable
• A Model for the Early Diagnosis of Colorectal Cancer by the Detection of 5-hydroxymethylcytosine (5-hmC) in Plasma Cell-free DNAStatus unknownNCT03599947
• Is Bronchoscopy Necessary in the Preoperative Workup of GGO Lung Cancer?(ECTOP-1005)CompletedNCT03591445Not applicable
• 500mg Fulvestrant Versus Exemestane in MBCCompletedNCT03575260
• Radiation-associated Carotid Artery Disease in Patients With Nasopharyngeal CarcinomaStatus unknownNCT03568032
• Treatment After Progression of Fulvestrant Among Metastatic Breast Cancer PatientsCompletedNCT03541863
• Potential Predictive Biomarkers in Patients Undergoing First-line Chemotherapy for Metastatic Colorectal CancerCompletedNCT03532711
• Rechallenge of Prior Regimen in Third or Later-line Chemotherapy in Metastatic Colorectal CancerCompletedNCT03485027Phase 2
• A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant AscitesStatus unknownNCT03475615Phase 3
• Detection of MicroRNA-25 in the Diagnosis of Pancreatic CancerStatus unknownNCT03432624
• Apatinib for Advanced Biliary CarcinomaStatus unknownNCT03427242Phase 2
• Safety and Efficacy of Statins for Chinese Patients With DyslipidemiaStatus unknownNCT03418974Phase 4
• Hypofractionated PBI After BCS for Low-risk Breast Cancer PatientsCompletedNCT03411174Not applicable
• Maintenance Chemotherapy in High-metastatic Risk Nasopharyngeal Carcinoma Patients of N3 StageStatus unknownNCT03403829Phase 3
• Apatinib in the Treatment of Metastatic Colorectal CancerStatus unknownNCT03403452Phase 2
• The Combination Chemotherapy of SIRIOX as First- or Second-Line Chemotherapy for Pancreatic CancerStatus unknownNCT03403101Phase 2
• XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC)CompletedNCT03399110Phase 3
• Onset of Labour Epidural Analgesia With Different Concentration Bupivacaine and Different Doses of SufentanylCompletedNCT03395600Phase 4
• A Clinical Study of Children With Status Epilepticus in ChinaStatus unknownNCT03378687
• Chidamide Combined With R-GDP in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)Status unknownNCT03373019Phase 2
• Study on the Brain Network of Angelman SyndromeCompletedNCT03358823
• Omics-based Precision Medicine of EpilepsyStatus unknownNCT03358459
• Simplification and Implementation of Awake Fibreoptic Orotracheal IntubationCompletedNCT03343496
• Thalidomide Combined With R-CHOP in Newly Diagnosed，Untreated Double-expressor Diffuse Large B-Cell Lymphoma PatientsStatus unknownNCT03318835Phase 3
• Peritoneal Lavage for Early Detecting Gene Mutation of Peritoneal Metastasis of Gastric CancerCompletedNCT03314649
• Selective Pelvic Lymphadenectomy for IB-IIA Cervical CancerStatus unknownNCT03295526Phase 2
• Analysis of Nutrition During Chemoradiotherapy in Patients With Gastrointestinal CancerStatus unknownNCT03286348
• Tissue-of-origin Directing Therapy in Patients With Cancer of Unknown PrimaryCompletedNCT03278600Phase 3
• Efficacy and Safety of Apatinib for Recurrent or Metastatic Esophageal Squamous Cell CarcinomaCompletedNCT03274011Phase 2
• Efficacy of Nasogastric Tube Application in Postoperative Care of EsophagectomyStatus unknownNCT03273686Phase 3
• Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma With Positive Circumstantial Resection MarginStatus unknownNCT03273647Phase 3
• PLD and IFO As First-line Treatment for Patients With Advanced or Metastatic STSStatus unknownNCT03268772Phase 2
• Vinorelbine Plus Apatinib Versus Vinorelbine in Advanced Triple-Negative Breast CancerCompletedNCT03254654Phase 2
• PD-1(Programmed Death-1) Antibody +GP as First Line Treatment for Triple Negative Breast Cancer(TNBC) PatientsStatus unknownNCT03251313Phase 1
• Effects of Epidural Anesthesia and Analgesia on the Prognosis in Patients Undergoing Pancreatic Cancer SurgeryCompletedNCT03245346Not applicable
• PET in Guiding Cervical Lymphadenectomy (ECTOP-2003)CompletedNCT03244566
• Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial CancerCompletedNCT03241914Phase 2/3
• Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical HyperplasiaCompletedNCT03241888Phase 2/3
• Mediastinal Staging Accuracy of a Selective Lymphadenectomy Strategy in Early Stage NSCLC (ECTOP-1003)CompletedNCT03216551
• The Efficacy of Fulvestrant in ESR1(Estrogen Receptor 1) Mutated Metastatic Breast CancerStatus unknownNCT03202862Phase 2
• Efficacy and Safety of Berberine in Non-alcoholic SteatohepatitisTerminatedNCT03198572Phase 2
• Case-control Study on Individual Risk Factors of CTSCompletedNCT03166033
• Stereotactic Body Radiation Therapy Combined With Anti-PD-1 Antibody in Metastatic Triple Negative Breast CancerStatus unknownNCT03151447Phase 1
• Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Unresectable CRLMStatus unknownNCT03127072Phase 4
• Study Comparing HAI Plus Chemotherapy and Chemotherapy Alone in Patients With Unresectable CRLMStatus unknownNCT03125161Phase 3
• Effects of Fermented Rye Bran Products on Helicobacter Pylori (HP) Infection and Metabolic Risk FactorsActive, not recruitingNCT03103386Not applicable
• Expression of Molecular Markers in Circulating Tumor Cells of Metastatic Castration-Resistant Prostate CancerStatus unknownNCT03089099
• The Value of Diffusion-weighted Imaging in Evaluating the Early Efficacy of Liver Metastasis in Colorectal CancerStatus unknownNCT03088163Not applicable
• Metronomic PLD in Patients With Primary Endocrine Resistant ABCStatus unknownNCT03071926Phase 2
• The Study of Targeted NY-ESO-1 T Cell Receptor (TCR) Genetic Modified Autologous T Cells Treatment of Advanced Solid TumorsStatus unknownNCT03047811Not applicable
• Safety and Risk Assessment of Obese Parturient Underwent Cesarean Section(CS) Delivery Under Different Anesthesia WaysCompletedNCT03002636Not applicable
• A Study of SBRT for OligoMetastatic ESCCCompletedNCT03000816Not applicable
• Pemetrexed and Platinum Use in the Neoadjuvant Setting for Resectable Stage II and IIIA Lung Adenocarcinoma (ECTOP-1002)CompletedNCT02980991Phase 2
• Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast CancerCompletedNCT02980965Phase 3
• Transanal Tube Drainage in Endoscopic Submucosal Dissection of the Colorectal TumorStatus unknownNCT02973490Not applicable
• Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Versus no HIPEC in Locally Advanced Colorectal Cancer (APEC Study)Status unknownNCT02965248Phase 3
• Endoscopic Submucosal Dissection (ESD) and Endoscopic Mucosal Band Ligation (EMBL) for Early CancerStatus unknownNCT02952794
• FOLFIRI Versus Irinotecan as Second-line Treatment in Metastatic Colorectal Cancer PatientsStatus unknownNCT02935764Phase 3
• Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy Concurrent With Chemotherapy for Esophageal Squamous Cell CarcinomaCompletedNCT02916511Phase 2
• Fulvestrant 500mg in Patients With Advanced Breast CancerStatus unknownNCT02909361
• Transanual Tube Placement in Low Anterior Resection (LAR) for Rectal CancerStatus unknownNCT02905968Phase 2/3
• The Maintenance Treatment of UFT in Advanced Gastric CancerCompletedNCT02903498Phase 2
• Robot-assisted Versus Laparoscopic Surgery for Mid/Low Rectal CancerStatus unknownNCT02817126Not applicable
• Clinical Trial of Adjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy Compared With Adjuvant Chemotherapy Alone in Patients With Gallbladder Carcinoma and Extrahepatic CholangiocarcinomaStatus unknownNCT02798510Phase 3
• The Study of Intraperitoneal Docetaxel Plus S-1 for Malignant AscitesStatus unknownNCT02779608Phase 2
• Laparoscopic Surgery VS Laparoscopic Surgery + Neoadjuvant Chemotherapy for T4 Tumor of the Colon CancerStatus unknownNCT02777437Phase 2/3
• A Prospective Clinical Study for Laparoscopic D3 Dissection With Preservation of Left Colic Artery in Rectal CancerStatus unknownNCT02753465Not applicable
• Sorafenib Combined With Aspirin to Prevent the Recurrence in High-risk Patients With Hepatocellular CarcinomaTerminatedNCT02748304Not applicable
• Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery)Status unknownNCT02742675Phase 2
• Compare S-1 for 6 Months to 1 Year as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer Staged II , IIIA or IIIB.WithdrawnNCT02736552Phase 3
• Expression of Tumor Markers in Circulating Tumor Cells of Metastatic Hormone-sensitive Prostate CancerStatus unknownNCT02723526
• Use of Cyclosporin A for the Treatment of Recurrent MiscarriageStatus unknownNCT02706470Phase 2/3

← Fudan University overview and focus areas